- Bee Vectoring (BEE) and BioSafe Systems have signed a memorandum of understanding (MOU) to collaborate on projects in the agricultural biologicals industry
- These projects will enable them to expand product offerings, markets and customer bases
- BioSafe Systems offers environmentally sustainable practices and products to protect crops, water and people across North America
- Bee Vectoring Technologies offers biological pesticide alternatives using commercially grown bees
- Bee Vectoring (BEE) is up by 18.18 per cent trading at $0.39 per share
Bee Vectoring (BEE) and BioSafe Systems have signed an MOU to collaborate on projects in the agricultural biologicals industry.
These projects will enable them to expand product offerings, markets and customer bases. Opportunities include pairing BioSafe biologicals with the company’s bee vectoring system, as well as using Bee Vectoring’s Clonostachys Rosea CR-7 strain for non-bee-vectoring applications.
“Our strategy is to build partnerships with established partners to accelerate our growth and broaden our customer reach,” stated Ashish Malik, Bee Vectoring’s CEO. “Therefore, being able to attract the attention of an industry leader such as BioSafe validates that our technology is gaining momentum among growers and in the market.”
“The mission of BioSafe Systems is to provide disease control solutions utilizing reduced-risk chemistries that do not negatively impact the health and safety of people and the environment,” added Rob Larose, President and CEO of BioSafe Systems. “We only develop, manufacture and promote products that meet our standards of environmentalism and sustainability, and BVT perfectly meets these key criteria.”
BioSafe Systems offers environmentally sustainable practices and products to protect crops, water and people across North America.
Bee Vectoring Technologies offers biological pesticide alternatives using commercially grown bees.
Bee Vectoring (BEE) is up by 18.18 per cent trading at $0.39 per share as of 2:12 pm EST.
